Literature DB >> 33663231

Could a Low-Dose Diuretic Polypill Improve Outcomes in Heart Failure With Preserved Ejection Fraction?

Sadiya S Khan1,2, Mark D Huffman1,2,3, Sanjiv J Shah1.   

Abstract

Entities:  

Keywords:  diuretics; heart failure; prevalence; thiazide

Mesh：

Substances：

Year:  2021        PMID： 33663231      PMCID： PMC7969434          DOI： 10.1161/CIRCHEARTFAILURE.120.008090

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  17 in total

1.  Disparities in Cardiovascular Mortality Related to Heart Failure in the United States.

Authors:  Peter Glynn; Donald M Lloyd-Jones; Matthew J Feinstein; Mercedes Carnethon; Sadiya S Khan
Journal:  J Am Coll Cardiol       Date:  2019-05-14       Impact factor: 24.094

2.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  John J V McMurray; Scott D Solomon; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; Inder S Anand; Jan Bělohlávek; Michael Böhm; Chern-En Chiang; Vijay K Chopra; Rudolf A de Boer; Akshay S Desai; Mirta Diez; Jaroslaw Drozdz; Andrej Dukát; Junbo Ge; Jonathan G Howlett; Tzvetana Katova; Masafumi Kitakaze; Charlotta E A Ljungman; Béla Merkely; Jose C Nicolau; Eileen O'Meara; Mark C Petrie; Pham N Vinh; Morten Schou; Sergey Tereshchenko; Subodh Verma; Claes Held; David L DeMets; Kieran F Docherty; Pardeep S Jhund; Olof Bengtsson; Mikaela Sjöstrand; Anna-Maria Langkilde
Journal:  N Engl J Med       Date:  2019-09-19       Impact factor: 91.245

3.  Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.

Authors:  James E Udelson; Gregory D Lewis; Sanjiv J Shah; Michael R Zile; Margaret M Redfield; John Burnett; John Parker; Jelena P Seferovic; Phebe Wilson; Robert S Mittleman; Albert T Profy; Marvin A Konstam
Journal:  JAMA       Date:  2020-10-20       Impact factor: 56.272

4.  Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao
Journal:  Circulation       Date:  2020-01-29       Impact factor: 29.690

Review 5.  The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.

Authors:  Wilfried Mullens; Kevin Damman; Veli-Pekka Harjola; Alexandre Mebazaa; Hans-Peter Brunner-La Rocca; Pieter Martens; Jeffrey M Testani; W H Wilson Tang; Francesco Orso; Patrick Rossignol; Marco Metra; Gerasimos Filippatos; Petar M Seferovic; Frank Ruschitzka; Andrew J Coats
Journal:  Eur J Heart Fail       Date:  2019-01-01       Impact factor: 15.534

6.  Dapagliflozin in Patients with Chronic Kidney Disease.

Authors:  Hiddo J L Heerspink; Bergur V Stefánsson; Ricardo Correa-Rotter; Glenn M Chertow; Tom Greene; Fan-Fan Hou; Johannes F E Mann; John J V McMurray; Magnus Lindberg; Peter Rossing; C David Sjöström; Roberto D Toto; Anna-Maria Langkilde; David C Wheeler
Journal:  N Engl J Med       Date:  2020-09-24       Impact factor: 91.245

7.  Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.

Authors:  Philip B Adamson; William T Abraham; Robert C Bourge; Maria Rosa Costanzo; Ayesha Hasan; Chethan Yadav; John Henderson; Pam Cowart; Lynne Warner Stevenson
Journal:  Circ Heart Fail       Date:  2014-10-06       Impact factor: 8.790

8.  2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Sandeep R Das; Brendan M Everett; Kim K Birtcher; Jenifer M Brown; James L Januzzi; Rita R Kalyani; Mikhail Kosiborod; Melissa Magwire; Pamela B Morris; Joshua J Neumiller; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2020-08-05       Impact factor: 24.094

9.  Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects.

Authors:  Christopher S Wilcox; Wen Shen; David W Boulton; Bruce R Leslie; Steven C Griffen
Journal:  J Am Heart Assoc       Date:  2018-02-10       Impact factor: 5.501

10.  Polypharmacy in Older Adults Hospitalized for Heart Failure.

Authors:  Ozan Unlu; Emily B Levitan; Evgeniya Reshetnyak; Jerard Kneifati-Hayek; Ivan Diaz; Alexi Archambault; Ligong Chen; Joseph T Hanlon; Mathew S Maurer; Monika M Safford; Mark S Lachs; Parag Goyal
Journal:  Circ Heart Fail       Date:  2020-10-13       Impact factor: 8.790
View more
  1 in total

Review 1.  Moving the Paradigm Forward for Prediction and Risk-Based Primary Prevention of Heart Failure in Special Populations.

Authors:  Ian K Everitt; Katherine V Trinh; Daniel L Underberg; Lauren Beach; Sadiya S Khan
Journal:  Curr Atheroscler Rep       Date:  2022-03-02       Impact factor: 5.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.